These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7643872)

  • 1. AAEM case report #29: Prolonged paralysis after neuromuscular blockade.
    Gooch JL
    Muscle Nerve; 1995 Sep; 18(9):937-42. PubMed ID: 7643872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged paralysis after neuromuscular blockade.
    Gooch JL
    J Toxicol Clin Toxicol; 1995; 33(5):419-26. PubMed ID: 7650766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids.
    Barohn RJ; Jackson CE; Rogers SJ; Ridings LW; McVey AL
    Muscle Nerve; 1994 Jun; 17(6):647-54. PubMed ID: 7910951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged paralysis after neuromuscular junction blockade: case reports and electrodiagnostic findings.
    Gooch JL; Moore MH; Ryser DK
    Arch Phys Med Rehabil; 1993 Sep; 74(9):1007-11. PubMed ID: 8379831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects.
    Lacomis D; Giuliani MJ; Van Cott A; Kramer DJ
    Ann Neurol; 1996 Oct; 40(4):645-54. PubMed ID: 8871585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prolonged paralysis after long-term administration of vecuronium in the intensive care unit].
    Tanaka O; Akai H; Takekida S; Tanaka Y; Wake M; Iijima K; Horikawa Y; Ijichi K
    Masui; 2006 Aug; 55(8):992-4. PubMed ID: 16910480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent paralysis in critically ill patients after long-term administration of vecuronium.
    Segredo V; Caldwell JE; Matthay MA; Sharma ML; Gruenke LD; Miller RD
    N Engl J Med; 1992 Aug; 327(8):524-8. PubMed ID: 1353252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical approach to the weak patient in the intensive care unit.
    Dhand UK
    Respir Care; 2006 Sep; 51(9):1024-40; discussion 1040-1. PubMed ID: 16934166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels.
    Larsson L; Li X; Edström L; Eriksson LI; Zackrisson H; Argentini C; Schiaffino S
    Crit Care Med; 2000 Jan; 28(1):34-45. PubMed ID: 10667496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prolonged neuromuscular block after a single dose of vecuronium in a patient with undiagnosed polyneuropathy and steroid myopathy].
    Rama-Maceiras P; Pensado A; Aymerich H; Molins N; Ferreira TA; Vázquez-Fidalgo A
    Rev Esp Anestesiol Reanim; 1999 Jan; 46(1):37-9. PubMed ID: 10073081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment.
    Danon MJ; Carpenter S
    Muscle Nerve; 1991 Nov; 14(11):1131-9. PubMed ID: 1684024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute necrotizing myopathy of intensive care: electrophysiological studies.
    Zochodne DW; Ramsay DA; Saly V; Shelley S; Moffatt S
    Muscle Nerve; 1994 Mar; 17(3):285-92. PubMed ID: 7906383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sedation after intubation using etomidate and a long-acting neuromuscular blocker.
    Kendrick DB; Monroe KW; Bernard DW; Tofil NM
    Pediatr Emerg Care; 2009 Jun; 25(6):393-6. PubMed ID: 19458564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The predominance of myopathy as a cause of intensive-care-unit-acquired paralysis: the diagnostic value of direct muscle stimulation].
    Nordine T; Lefaucheur JP
    Rev Neurol (Paris); 2007 Feb; 163(2):181-7. PubMed ID: 17351537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged paralysis after treatment with neuromuscular junction blocking agents.
    Gooch JL; Suchyta MR; Balbierz JM; Petajan JH; Clemmer TP
    Crit Care Med; 1991 Sep; 19(9):1125-31. PubMed ID: 1679384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myopathy and prolonged neuromuscular blockade after lung transplant.
    Subramony SH; Carpenter DE; Raju S; Pride M; Evans OB
    Crit Care Med; 1991 Dec; 19(12):1580-2. PubMed ID: 1683618
    [No Abstract]   [Full Text] [Related]  

  • 17. Vecuronium induced prolonged paralysis in two pediatric intensive care patients.
    Kendirli T; Incesoy S; Ince E; Tutar E
    Can J Neurol Sci; 2005 Feb; 32(1):130-1. PubMed ID: 15825561
    [No Abstract]   [Full Text] [Related]  

  • 18. Muscle weakness in mechanically ventilated patients with severe asthma.
    Leatherman JW; Fluegel WL; David WS; Davies SF; Iber C
    Am J Respir Crit Care Med; 1996 May; 153(5):1686-90. PubMed ID: 8630621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of implementation of neuromuscular blockade monitoring standards in a surgical intensive care unit.
    Frankel H; Jeng J; Tilly E; St Andre A; Champion H
    Am Surg; 1996 Jun; 62(6):503-6. PubMed ID: 8651538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged muscle weakness after neuromuscular blockade in the intensive care unit.
    Raps EC; Bird SJ; Hansen-Flaschen J
    Crit Care Clin; 1994 Oct; 10(4):799-813. PubMed ID: 8000927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.